Skip to main content
. 2013 Feb;344(2):319–328. doi: 10.1124/jpet.112.198374

Fig. 4.

Fig. 4.

Effects of the cannabinoid CB1 receptor antagonists SR141716A and AM4113 administered i.v. via the tail vein in squirrel monkeys responding under the FR30 schedule of stimulus-shock termination. Other details are as in Fig. 2.